Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
D000613:Aminobutyrates / Q000031:analogs & derivatives / Q000494:pharmacology; D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002228:Carbenicillin / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology*; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology*; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010303:Paromomycin / Q000494:pharmacology*; D010403:Penicillin Resistance; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013997:Time Factors
D000613:Aminobutyrates; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D010303:Paromomycin; D002228:Carbenicillin; D002512:Cephalothin